CTOs on the Move

Enveric Biosciences

www.enveric.com

 
Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.enveric.com
  • 4851 Tamiami Trail N Suite 200
    Naples, FL USA 34103
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Enveric Biosciences raised $10M on 01/12/2021
Enveric Biosciences raised $12.8M on 02/09/2021

Similar Companies

Ultimed

Ultimed is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cetylite Industries Inc

Cetylite Industries Inc is a Pennsauken, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PRC

PRC is a global leader in AAC Solutions including for individuals with speech disorders. *This group does not provide official technical support.

Shenzhen Hepalink Pharmaceutical Co.

Hepalink was established in 1998 and restructured in 2007 to be a limited liability company.

Vivera Pharmaceuticals

Vivera Pharmaceuticals is an innovative, science-driven pharmaceutical company located in Southern California. The Company has global exclusivity to license the patented and patent-pending TABMELT® sublingual drug delivery system for pharmaceutical use and holds its own issued patents on ZICOH®, a smart dose-controlled medical device. With multiple divisions, including its pharmaceutical, neurosciences, medical technology, biosciences, and advanced diagnostics divisions, Vivera Pharmaceuticals is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products.